Acute myelogenous leukemia : progress and controversies, proceedings of a Wyeth-Ayerst-UCLA Symposia Western Workshop held at Lake Lanier, Georgia, november 28 december 1, 1989
This examination of acute myelogenous leukemia (AML) discusses the pathogenesis of this disease and new and emerging therapeutic approaches. Chapters cover subjects ranging from leukemia in atomic bomb surviviors to the pharmacologically directed design of AML.
Print Book, English, 1990
Wiley-Liss, New York, 1990
500 p. ; 23 cm.
Etiology - additional observations on high risk of leukemia, R.Miller; possible relationship of exposure to low energy electromagnetic fields and cancer, C.Byus; molecular and cellular biology - the biology of blast cells in acute myeloblastic leukemia, E.McCulloch; analysis of clonal cell populations in human leukemia, A.Turhan et al; clinical aspects - cytogenetic abnormalities in childhood AML, D.Kalwinsky et al; response to treatment in acute myelogenous leukemia, H.Preisler; chemotherapy - children - evaluating therapy for AML, A.Keating and R.Gale; AML trials at St.Jude Children's Research Hospital, J.Mirro et al; chemotherapy - adults - effect of exclusion criteria on interpretation of clinical outcome in AML, A.Keating and M.Baker; survival with acute myelogenous leukemia, A.Rohatiner et al; transplants - strategies to treat acute myelogenous leukemia, R.Gale and A.Butturini; bone marrow transplantation for AML, E.Estey et al; acute myelogenous leukemia - progress and controversies, R.Gale.